Chronic oral etoposide in non-small cell lung carcinoma
- 1 April 1992
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 28 (4-5) , 835-837
- https://doi.org/10.1016/0959-8049(92)90126-m
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Prolonged administration of oral etoposide in patients with relapsed or refractory small-cell lung cancer: a phase II trial.Journal of Clinical Oncology, 1990
- Combination Chemotherapy with Oral Etoposide plus Intravenous Cyclophosphamide in Liver Metastases of Breast CancerAmerican Journal of Clinical Oncology, 1990
- A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer.Journal of Clinical Oncology, 1989
- Chronic daily administration of oral etoposide--a phase I trial.Journal of Clinical Oncology, 1989
- Confidence Intervals for Reporting Results of Clinical TrialsAnnals of Internal Medicine, 1986
- The effect of food and concurrent chemotherapy on the bioavailability of oral etoposideBritish Journal of Cancer, 1985
- Etoposide (VP-16–213)New England Journal of Medicine, 1985
- VP16-213 and cyclophosphamide in advanced breast cancerCancer Chemotherapy and Pharmacology, 1983
- VP-16 plus cyclophosphamide in the treatment of advanced lung cancerCancer, 1983
- Reporting results of cancer treatmentCancer, 1981